Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Irwin Naturals Inc
(OP:
IWINF
)
0.5000
UNCHANGED
Last Price
Updated: 9:33 AM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.5000
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.5000
Today's Range
0.5000 - 0.5000
52wk Range
0.0500 - 0.9544
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Irwin Naturals Sued By East West Bank Over $40M Loan Default
August 13, 2024
Irwin Naturals faces a $40M loan lawsuit from East West Bank, leading to Chapter 11 bankruptcy. Explore the implications for the supplements company and its investors.
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Defense Dept. Funds Ketamine Study For PTSD Treatment
Via
Benzinga
Performance
YTD
+122.42%
+122.42%
1 Month
+11.09%
+11.09%
3 Month
+66.67%
+66.67%
6 Month
+587.76%
+587.76%
1 Year
-47.60%
-47.60%
More News
Read More
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
November 28, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Via
Benzinga
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
July 28, 2023
Via
Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
August 28, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
June 01, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Via
Benzinga
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
May 26, 2023
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
Via
Benzinga
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
May 05, 2023
Via
Benzinga
Cannabis Stock Movers For July 27, 2023
July 27, 2023
Via
Benzinga
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
May 03, 2023
Via
Benzinga
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
May 01, 2023
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
March 27, 2023
Via
Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
March 24, 2023
Via
Benzinga
Irwin Naturals Acquires Ketamine Media
March 22, 2023
Via
Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
Via
Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
March 16, 2023
Via
Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
March 15, 2023
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.